When SGLT2 inhibitors are used in children with HF, it is important to monitor for adverse effects, including dehydration, urinary tract infections, genital infections, hypoglycemia, diabetic ketoacidosis, and hypotension, among others. Here, SLC5A2 is linked to hydrops fetalis.